- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Drug development in Alzheimer’s disease: the path to 2025 ; volume:8 ; number:1 ; day:20 ; month:9 ; year:2016 ; pages:1-12 ; date:12.2016
Alzheimer's research & therapy ; 8, Heft 1 (20.9.2016), 1-12, 12.2016
- Creator
- Contributor
-
Aisen, Paul S.
Dubois, Bruno
Frölich, Lutz
Jack, Clifford R.
Jones, Roy W.
Morris, John C.
Raskin, Joel
Dowsett, Sherie A.
Scheltens, Philip
SpringerLink (Online service)
- DOI
-
10.1186/s13195-016-0207-9
- URN
-
urn:nbn:de:1111-201610152507
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cummings, Jeffrey L.
- Aisen, Paul S.
- Dubois, Bruno
- Frölich, Lutz
- Jack, Clifford R.
- Jones, Roy W.
- Morris, John C.
- Raskin, Joel
- Dowsett, Sherie A.
- Scheltens, Philip
- SpringerLink (Online service)
Other Objects (12)
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
The “rights” of precision drug development for Alzheimer’s disease
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
On the path to 2025: understanding the Alzheimer’s disease continuum
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
The “rights” of precision drug development for Alzheimer’s disease
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
On the path to 2025: understanding the Alzheimer’s disease continuum
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
The “rights” of precision drug development for Alzheimer’s disease
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
On the path to 2025: understanding the Alzheimer’s disease continuum
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing